Sunlight and health: shifting the focus from vitamin D3 to photobiomodulation by red and near-infrared light.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing preclinical mechanisms and preliminary clinical trials without systematic review methodology
PubMed 32464190 · doi:10.1016/j.arr.2020.101089
What was done
This narrative review examined the discrepancy between epidemiological studies linking sunlight exposure to reduced chronic disease and all-cause mortality versus randomized trials and Mendelian randomization studies showing minimal benefit from vitamin D supplementation. The authors evaluated evidence from animal models and preliminary human randomized controlled trials on red and near-infrared light (photobiomodulation) as an alternative explanatory mechanism.
What was found
The abstract reports no numerical data, effect sizes, or statistical metrics. It notes qualitatively that vitamin D supplementation has largely failed to confirm major health benefits in randomized trials, while red and near-infrared light exposure demonstrates beneficial effects in animal models and preliminary clinical benefit in early randomized trials for age-related chronic diseases.
Why it matters
It shifts the theoretical framework for sunlight's protective associations from vitamin D synthesis to photobiomodulation by red and near-infrared wavelengths, highlighting an alternative target for chronic disease prevention research.
Limits
The abstract provides no quantitative data or systematic review methodology. The hypothesis rests largely on animal models and preliminary clinical trials, meaning human efficacy, optimal dosing, and long-term clinical outcomes remain unproven pending larger ongoing trials.
Cited by
- context Plant foliage reflects near-infrared light that penetrates the human body surface and stimulates mitochondrial function.